Review



irisin inhibitor rgds  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress irisin inhibitor rgds
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Irisin Inhibitor Rgds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/irisin inhibitor rgds/product/MedChemExpress
    Average 94 stars, based on 13 article reviews
    irisin inhibitor rgds - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription"

    Article Title: Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription

    Journal: Cell Communication and Signaling : CCS

    doi: 10.1186/s12964-025-02463-x

    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Figure Legend Snippet: Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Techniques Used: Infection, Staining, Western Blot, Immunoprecipitation, Ubiquitin Proteomics, Co-Immunoprecipitation Assay



    Similar Products

    irisin inhibitor rgds  (MedChemExpress)
    94
    MedChemExpress irisin inhibitor rgds
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Irisin Inhibitor Rgds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/irisin inhibitor rgds/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    irisin inhibitor rgds - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    arg gly asp  (MedChemExpress)
    93
    MedChemExpress arg gly asp
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Arg Gly Asp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/arg gly asp/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    arg gly asp - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    rgds  (MedChemExpress)
    94
    MedChemExpress rgds
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Rgds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rgds/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    rgds - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)) (purity>95)  (Bankpeptide biological technology co LTD)
    90
    Bankpeptide biological technology co LTD c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)) (purity>95)
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    C(Rgdfk) Peptide Sequence (C(Arg Gly Asp D Phe Lys)) (Purity>95), supplied by Bankpeptide biological technology co LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)) (purity>95)/product/Bankpeptide biological technology co LTD
    Average 90 stars, based on 1 article reviews
    c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)) (purity>95) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cyclo[arg-gly-asp-d-phe-lys(biotin)] crgd-biotin  (Biosynth Carbosynth)
    90
    Biosynth Carbosynth cyclo[arg-gly-asp-d-phe-lys(biotin)] crgd-biotin
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Cyclo[Arg Gly Asp D Phe Lys(Biotin)] Crgd Biotin, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclo[arg-gly-asp-d-phe-lys(biotin)] crgd-biotin/product/Biosynth Carbosynth
    Average 90 stars, based on 1 article reviews
    cyclo[arg-gly-asp-d-phe-lys(biotin)] crgd-biotin - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cyclo[arg-gly-asp-d-phe-lys(peg-peg-azide)] rgd-3759-pi  (Biosynth Carbosynth)
    90
    Biosynth Carbosynth cyclo[arg-gly-asp-d-phe-lys(peg-peg-azide)] rgd-3759-pi
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Cyclo[Arg Gly Asp D Phe Lys(Peg Peg Azide)] Rgd 3759 Pi, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclo[arg-gly-asp-d-phe-lys(peg-peg-azide)] rgd-3759-pi/product/Biosynth Carbosynth
    Average 90 stars, based on 1 article reviews
    cyclo[arg-gly-asp-d-phe-lys(peg-peg-azide)] rgd-3759-pi - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)  (Bankpeptide biological technology co LTD)
    90
    Bankpeptide biological technology co LTD c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    C(Rgdfk) Peptide Sequence (C(Arg Gly Asp D Phe Lys), supplied by Bankpeptide biological technology co LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys)/product/Bankpeptide biological technology co LTD
    Average 90 stars, based on 1 article reviews
    c(rgdfk) peptide sequence (c(arg-gly-asp-d-phe-lys) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    cyclo [arg-gly-asp-d-phe-lys(biotin-peg-peg)] rgd  (Biosynth Carbosynth)
    90
    Biosynth Carbosynth cyclo [arg-gly-asp-d-phe-lys(biotin-peg-peg)] rgd
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Cyclo [Arg Gly Asp D Phe Lys(Biotin Peg Peg)] Rgd, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cyclo [arg-gly-asp-d-phe-lys(biotin-peg-peg)] rgd/product/Biosynth Carbosynth
    Average 90 stars, based on 1 article reviews
    cyclo [arg-gly-asp-d-phe-lys(biotin-peg-peg)] rgd - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    rgd based peptide crgdfk  (Biosynth Carbosynth)
    92
    Biosynth Carbosynth rgd based peptide crgdfk
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    Rgd Based Peptide Crgdfk, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rgd based peptide crgdfk/product/Biosynth Carbosynth
    Average 92 stars, based on 1 article reviews
    rgd based peptide crgdfk - by Bioz Stars, 2026-02
    92/100 stars
    		  Buy from Supplier
    p257–81 peptide (phe-lys-asn-thr-glu-ile-ser-phe-lys-leu-gly-gln-glu-pheglu-glu-thr-thr-ala-asp-asn-arg-lys-thr-lys)  (GL Biochem)
    90
    GL Biochem p257–81 peptide (phe-lys-asn-thr-glu-ile-ser-phe-lys-leu-gly-gln-glu-pheglu-glu-thr-thr-ala-asp-asn-arg-lys-thr-lys)
    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without <t>irisin</t> <t>inhibitor</t> <t>RGDS.</t> (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001
    P257–81 Peptide (Phe Lys Asn Thr Glu Ile Ser Phe Lys Leu Gly Gln Glu Pheglu Glu Thr Thr Ala Asp Asn Arg Lys Thr Lys), supplied by GL Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p257–81 peptide (phe-lys-asn-thr-glu-ile-ser-phe-lys-leu-gly-gln-glu-pheglu-glu-thr-thr-ala-asp-asn-arg-lys-thr-lys)/product/GL Biochem
    Average 90 stars, based on 1 article reviews
    p257–81 peptide (phe-lys-asn-thr-glu-ile-ser-phe-lys-leu-gly-gln-glu-pheglu-glu-thr-thr-ala-asp-asn-arg-lys-thr-lys) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cell Communication and Signaling : CCS

    Article Title: Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription

    doi: 10.1186/s12964-025-02463-x

    Figure Lengend Snippet: Irisin down-regulates PIAS4 to repress EHMT2 SUMOylation, thereby promoting osteogenic differentiation. MSCs were infected with lentivirus containing oe-NC or oe-PIAS4 with or without irisin together. A Osteogenic differentiation potential was evaluated by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). B Western blotting analysis of protein levels of PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1. (C) Cells were lysed and immunoprecipitated with EHMT2 antibody and then immunoblotted with SUMO2/3 or EHMT2 antibody. MSCs were treated with irisin together with or without irisin inhibitor RGDS. (D) Osteogenic differentiation potential was determined by ALP and ARS staining, and quantitative analysis was provided (scale bar = 100 μm). (E) The protein levels of FAK, p-FAK, SKP2, PIAS4, EHMT2, DLX3, Runx2, OCN, OPN, and Colla1 were assessed by Western blotting. (F) Cell lysates were immunoprecipitated with EHMT2 antibody, followed by immunoblotting with SUMO2/3 or EHMT2 antibody. (G) Ubiquitin level of EHMT2 was analyzed by Co-IP. n = 3. One-way ANOVA (for B, E) was performed for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: MSCs were treated with 100 ng/mL irisin (MCE, NJ, USA) together with or without irisin inhibitor RGDS (100 nM, MCE) for 48 h.

    Techniques: Infection, Staining, Western Blot, Immunoprecipitation, Ubiquitin Proteomics, Co-Immunoprecipitation Assay